NO178862C - Fremgangsmåte for fremstilling av intracellulært adhesjonsmolekyl - 2 eller et funksjonelt derivat derav - Google Patents

Fremgangsmåte for fremstilling av intracellulært adhesjonsmolekyl - 2 eller et funksjonelt derivat derav

Info

Publication number
NO178862C
NO178862C NO901093A NO901093A NO178862C NO 178862 C NO178862 C NO 178862C NO 901093 A NO901093 A NO 901093A NO 901093 A NO901093 A NO 901093A NO 178862 C NO178862 C NO 178862C
Authority
NO
Norway
Prior art keywords
molecules
preparation
adhesion molecule
functional derivative
intracellular adhesion
Prior art date
Application number
NO901093A
Other languages
English (en)
Norwegian (no)
Other versions
NO901093D0 (no
NO178862B (no
NO901093L (no
Inventor
Timothy Alan Springer
Michael Loran Dustin
Donald E Staunton
Original Assignee
Blood Res Center
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Blood Res Center filed Critical Blood Res Center
Publication of NO901093D0 publication Critical patent/NO901093D0/no
Publication of NO901093L publication Critical patent/NO901093L/no
Publication of NO178862B publication Critical patent/NO178862B/no
Publication of NO178862C publication Critical patent/NO178862C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70503—Immunoglobulin superfamily
    • C07K14/70525—ICAM molecules, e.g. CD50, CD54, CD102
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2803—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily
    • C07K16/2821—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the immunoglobulin superfamily against ICAM molecules, e.g. CD50, CD54, CD102
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Toxicology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • General Engineering & Computer Science (AREA)
  • Cell Biology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO901093A 1989-03-09 1990-03-08 Fremgangsmåte for fremstilling av intracellulært adhesjonsmolekyl - 2 eller et funksjonelt derivat derav NO178862C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US32123889A 1989-03-09 1989-03-09
US45429489A 1989-12-22 1989-12-22

Publications (4)

Publication Number Publication Date
NO901093D0 NO901093D0 (no) 1990-03-08
NO901093L NO901093L (no) 1990-09-10
NO178862B NO178862B (no) 1996-03-11
NO178862C true NO178862C (no) 1996-06-19

Family

ID=26982877

Family Applications (1)

Application Number Title Priority Date Filing Date
NO901093A NO178862C (no) 1989-03-09 1990-03-08 Fremgangsmåte for fremstilling av intracellulært adhesjonsmolekyl - 2 eller et funksjonelt derivat derav

Country Status (16)

Country Link
EP (1) EP0387668B1 (fr)
JP (1) JP3369166B2 (fr)
KR (1) KR0169728B1 (fr)
AT (1) ATE146222T1 (fr)
AU (1) AU647017B2 (fr)
CA (1) CA2011633C (fr)
DE (1) DE69029336T2 (fr)
DK (1) DK0387668T3 (fr)
ES (1) ES2097747T3 (fr)
FI (1) FI100994B (fr)
GR (1) GR3022670T3 (fr)
HU (1) HU214247B (fr)
IL (1) IL93680A (fr)
MX (1) MX9203469A (fr)
NO (1) NO178862C (fr)
NZ (2) NZ232833A (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143298A (en) * 1988-09-01 2000-11-07 Bayer Corporation Soluble truncated forms of ICAM-1
US6051231A (en) * 1988-09-01 2000-04-18 Bayer Corporation Antiviral methods and prepations
US6514936B1 (en) 1988-09-01 2003-02-04 Bayer Corporation Antiviral methods using human rhinovirus receptor (ICAM-1)
ZA896668B (en) * 1988-09-01 1990-06-27 Molecular Therapeutics Inc A human rhinovirus receptor protein that inhibits virus infectivity
HU217792B (hu) * 1989-03-16 2000-04-28 Dana Farber Cancer Institute Eljárás intercelluláris adhéziós molekula (ICAM-1) oldható származékai és ezeket tartalmazó gyógyszerkészítmények előállítására
ES2134762T3 (es) * 1990-07-20 1999-10-16 Bayer Ag Formas multimericas de proteinas receptoras de rinovirus humanos.
US5686582A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric forms of human rhinovirus receptor protein
US6107461A (en) * 1990-07-20 2000-08-22 Bayer Corporation Multimeric forms of human rhinovirus receptor and fragments thereof, and method of use
US5686581A (en) * 1990-07-20 1997-11-11 Bayer Corporation Multimeric form of human rhinovirus receptor protein
EP0510483A1 (fr) * 1991-04-22 1992-10-28 Boehringer Ingelheim Pharmaceuticals Inc. Procédé pour la détection des virus
US5460945A (en) * 1991-05-30 1995-10-24 Center For Blood Research, Inc. Device and method for analysis of blood components and identifying inhibitors and promoters of the inflammatory response
US5629162A (en) * 1991-06-11 1997-05-13 The Center For Blood Research Method of identifying agents which modulate ICAM-3 binding to LFA-1
IL102176A (en) * 1991-06-11 2001-09-13 Blood Res Center Recombinant nucleic acid molecule capable of encoding intercellular adhesion molecule 3, functional derivatives of icam-3 and pharmaceutical compositions containing icam-3 or functional derivatives thereof
US5861151A (en) * 1991-12-20 1999-01-19 Bristol-Myers Squibb Co Soluble fusion molecules with binding specificity for cell adhesion molecules
US5811517A (en) * 1992-01-27 1998-09-22 Icos Corporation ICAM-related protein variants
US6100383A (en) * 1992-01-27 2000-08-08 Icos Corporation Fusion proteins comprising ICAM-R polypeptides and immunoglobulin constant regions
WO1993014776A1 (fr) * 1992-01-27 1993-08-05 Icos Corporation Proteine apparentee a icam
US5525487A (en) * 1992-01-27 1996-06-11 Icos Corporation DNA encoding I-CAM related protein
US5837822A (en) * 1992-01-27 1998-11-17 Icos Corporation Humanized antibodies specific for ICAM related protein
US5989843A (en) * 1992-01-27 1999-11-23 Icos Corporation Methods for identifying modulators of protein kinase C phosphorylation of ICAM-related protein
US6818743B1 (en) 1992-01-27 2004-11-16 Icos Corporation I-CAM related protein
US6153395A (en) * 1992-01-27 2000-11-28 Icos Corporation ICAM-related protein
US5532127A (en) * 1992-01-27 1996-07-02 Icos Corporation Assay for 1-CAM related protein expression
CA2131190C (fr) * 1992-02-28 2008-08-12 Peter E. Lipsky Compositions et methodes pour traiter les blessures par brulure
AU687755B2 (en) * 1992-08-21 1998-03-05 Genentech Inc. Method for treating an LFA-1-mediated disorder
WO1994011400A1 (fr) * 1992-11-18 1994-05-26 Helsinki University Licensing Ltd. Oy Peptides de icam-2 et icam-1 chez l'homme et leurs analogues s'utilisant en therapie et diagnostic
WO1997011168A1 (fr) * 1995-09-22 1997-03-27 Relag Pty. Limited Promoteur et ses utilisations
US5914112A (en) * 1996-01-23 1999-06-22 Genentech, Inc. Anti-CD18 antibodies in stroke
US20020081294A1 (en) 1996-01-23 2002-06-27 Genentech, Inc. Co-administration of a thrombolytic and an anti-CD18 antibody in stroke
US6582698B1 (en) 1999-03-19 2003-06-24 Genentech, Inc. Treatment method
JP2002540078A (ja) 1999-03-19 2002-11-26 ジェネンテック・インコーポレーテッド Ｌｆａ−１アンタゴニスト投与量の増加によるｌｆａ−１関連疾患の治療
RU2006146939A (ru) 2004-06-09 2008-07-20 Дженентек Способ лечения кольцевидной гранулемы или саркоида

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2080044T3 (es) * 1987-05-04 1996-02-01 Dana Farber Cancer Inst Inc Moleculas de adhesion intercelular y sus ligandos de fijacion.
AU629189B2 (en) * 1987-05-04 1992-10-01 Dana-Farber Cancer Institute Intercellular adhesion molecules and their binding ligands
WO1989008114A1 (fr) * 1988-02-25 1989-09-08 The General Hospital Corporation Procede de clonage par immunoselection rapide
ATE219838T1 (de) * 1989-03-16 2002-07-15 Blood Res Center Verwendung von funktionellen derivaten des interzellulär-adhäsions-moleküls icam-1 in einer antivirus-therapie

Also Published As

Publication number Publication date
IL93680A (en) 1996-01-31
ATE146222T1 (de) 1996-12-15
IL93680A0 (en) 1990-12-23
NO901093D0 (no) 1990-03-08
DE69029336T2 (de) 1997-07-03
HU901367D0 (en) 1990-05-28
FI100994B (fi) 1998-03-31
NO178862B (no) 1996-03-11
HU214247B (hu) 1998-03-02
MX9203469A (es) 1992-07-01
EP0387668A1 (fr) 1990-09-19
DE69029336D1 (de) 1997-01-23
DK0387668T3 (da) 1997-03-03
JP3369166B2 (ja) 2003-01-20
ES2097747T3 (es) 1997-04-16
NO901093L (no) 1990-09-10
EP0387668B1 (fr) 1996-12-11
AU5117290A (en) 1990-09-13
AU647017B2 (en) 1994-03-17
GR3022670T3 (en) 1997-05-31
NZ245651A (en) 1997-06-24
JPH0361486A (ja) 1991-03-18
FI901170A0 (fi) 1990-03-08
CA2011633C (fr) 2007-05-15
NZ232833A (en) 1993-05-26
CA2011633A1 (fr) 1990-09-09
KR0169728B1 (ko) 1999-01-15
KR900013978A (ko) 1990-10-22

Similar Documents

Publication Publication Date Title
NO178862C (no) Fremgangsmåte for fremstilling av intracellulært adhesjonsmolekyl - 2 eller et funksjonelt derivat derav
FI882037A0 (fi) Intercellulaera adhesionmolekyler och deras bindande ligander.
DE68923675D1 (de) Interzellulare Adhäsions-Moleküle und deren Bindungsliganden.
FI893916A0 (fi) Alfa-subenhet av lfa-1 -leukocytadhesionsreceptor.
FI915150A7 (fi) Menetelmät, reagenssit ja testikäyttöpakkaukset biologisten yksiköiden alapopulaatioiden määrittämiseksi
RU93058655A (ru) Антитела, способ получения клетки, способ изменения функций клеток, способ подавления инфицирования, способ подавления роста клеток, способы диагностики
EP0364690A3 (fr) Sous-unité du récepteur d'adhésion de leukocyte Mac-1
GR3036138T3 (en) A screening method for identifying ligands for target proteins
AU3395084A (en) Polypeptide-induced monoclonal receptors to protein ligands
DE69132238D1 (de) Verfahren zur Stabilisierung von Enzym-Konjugaten

Legal Events

Date Code Title Description
MK1K Patent expired